BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 9169819)

  • 1. Chemotherapy and low-dose radiotherapy in the treatment of HIV-infected patients with carcinoma of the anal canal.
    Peddada AV; Smith DE; Rao AR; Frost DB; Kagan AR
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1101-5. PubMed ID: 9169819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined modality therapy for HIV-infected patients with squamous cell carcinoma of the anus: outcomes and toxicities.
    Edelman S; Johnstone PA
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):206-11. PubMed ID: 16904522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience.
    Salama JK; Mell LK; Schomas DA; Miller RC; Devisetty K; Jani AB; Mundt AJ; Roeske JC; Liauw SL; Chmura SJ
    J Clin Oncol; 2007 Oct; 25(29):4581-6. PubMed ID: 17925552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness.
    Ferrigno R; Nakamura RA; Dos Santos Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV; Filho WJ; Lopes A
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1136-42. PubMed ID: 15752894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08.
    John M; Pajak T; Flam M; Hoffman J; Markoe A; Wolkov H; Paris K
    Cancer J Sci Am; 1996; 2(4):205-11. PubMed ID: 9166533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary chemoradiation therapy with fluorouracil and cisplatin for cancer of the anus: results in 35 consecutive patients.
    Doci R; Zucali R; La Monica G; Meroni E; Kenda R; Eboli M; Lozza L
    J Clin Oncol; 1996 Dec; 14(12):3121-5. PubMed ID: 8955657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic index.
    Hung A; Crane C; Delclos M; Ballo M; Ajani J; Lin E; Feig B; Skibber J; Janjan N
    Cancer; 2003 Mar; 97(5):1195-202. PubMed ID: 12599225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].
    Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M
    Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Squamous-cell carcinoma of the anus in HIV-positive patients.
    Chadha M; Rosenblatt EA; Malamud S; Pisch J; Berson A
    Dis Colon Rectum; 1994 Sep; 37(9):861-5. PubMed ID: 8076484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermoid carcinoma of the anal canal: treatment by combined radiation and chemotherapy.
    Grabenbauer GG; Schneider IH; Gall FP; Sauer R
    Radiother Oncol; 1993 Apr; 27(1):59-62. PubMed ID: 8327734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined chemoradiation therapy for anal cancer. A report of 56 cases.
    Doci R; Zucali R; Bombelli L; Montalto F; Lamonica G
    Ann Surg; 1992 Feb; 215(2):150-6. PubMed ID: 1546901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Definitive chemoradiotherapy for anal canal cancer: single-center experience.
    Tachibana I; Nishimura Y; Inada M; Fukuda K; Ishikawa K; Nishikawa T; Yokokawa M; Nakamatsu K; Kanamori S; Hida JI
    Int J Clin Oncol; 2018 Dec; 23(6):1121-1126. PubMed ID: 29992389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent chemoradiotherapy with 5-fluorouracil and mitomycin C for invasive anal carcinoma in human immunodeficiency virus-positive patients receiving highly active antiretroviral therapy.
    Fraunholz I; Weiss C; Eberlein K; Haberl A; Rödel C
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1425-32. PubMed ID: 19744801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction therapy for poor-prognosis anal canal carcinoma: a phase II study of the cancer and Leukemia Group B (CALGB 9281).
    Meropol NJ; Niedzwiecki D; Shank B; Colacchio TA; Ellerton J; Valone F; Budinger S; Day JM; Hopkins J; Tepper J; Goldberg RM; Mayer RJ
    J Clin Oncol; 2008 Jul; 26(19):3229-34. PubMed ID: 18490648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Squamous cell carcinoma of the anal canal.
    Mitchell SE; Mendenhall WM; Zlotecki RA; Carroll RR
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):1007-13. PubMed ID: 11240241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Concurrent chemoradiotherapy for squamous cell carcinoma of the anal canal-report of four cases].
    Kinjo A; Ogawa K; Iraha S; Tamaki W; Toita T; Kakinohana Y; Samura H; Kinjo I; Nishimaki T; Kuniyoshi Y; Murayama S
    Gan To Kagaku Ryoho; 2008 Mar; 35(3):519-22. PubMed ID: 18347409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer of the anal canal: treatment with chemotherapy and low-dose radiation therapy.
    Smith DE; Shah KH; Rao AR; Frost DB; Latino F; Anderson PJ; Peddada AV; Kagan AR
    Radiology; 1994 May; 191(2):569-72. PubMed ID: 8153343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial.
    Ajani JA; Winter KA; Gunderson LL; Pedersen J; Benson AB; Thomas CR; Mayer RJ; Haddock MG; Rich TA; Willett C
    JAMA; 2008 Apr; 299(16):1914-21. PubMed ID: 18430910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of chemoradiotherapy with 5-Fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients.
    Seo Y; Kinsella MT; Reynolds HL; Chipman G; Remick SC; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):143-9. PubMed ID: 19203845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy.
    Kachnic LA; Tsai HK; Coen JJ; Blaszkowsky LS; Hartshorn K; Kwak EL; Willins JD; Ryan DP; Hong TS
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):153-8. PubMed ID: 21095071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.